Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non‐small cell lung cancer patients: A meta‐analysis

BACKGROUND: Differences in the resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in patients with non‐small cell lung cancer (NSCLC) harboring epidermal growth factor receptor mutations are unknown. This meta‐analysis aimed to clarify the differences in resistance...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Kobayashi, Nobuaki, Katakura, Seigo, Kamimaki, Chisato, Somekawa, Kohei, Fukuda, Nobuhiko, Tanaka, Katsushi, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Piao, Hongmei, Kaneko, Takeshi
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2021
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8017253/
https://ncbi.nlm.nih.gov/pubmed/33565276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13878
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi